Dear Sir / Madam, Greetings from ESICON 2020. Because of ongoing Covid 19 secnario the ESI has postponed its annual meeting scheduled in September i.e 10 to 13, Will communicate with you our new dates Later.
North America Faculty
Dr.RavikumarBalasubramanian is a Reproductive Endocrinologist in the Reproductive Endocrine Unit at the Massachusetts General Hospital and Asst Professor of Medicine at Harvard Medical School, Boston, USA. He is currently a Key Investigator at the Harvard National Center for Translational Research in Infertility and is supported by multiple research awards from the National Institutes of Health. His research focuses on discovering novel genetic pathways controlling human reproduction. His specialist clinical interest is in treating patients with Kallmann Syndrome and hypogonadotropichypogonadism. He has been invited as a faculty lecturer to several international research meetings and postgraduate reproductive endocrinology courses.
Constantine A. Stratakis is internationally recognized for his research, mentorship, and leadership. Dr. Stratakis has been extremely successful in employing genetic linkage and other genome-wide tools to identify most of the genes known to be responsible for adrenocortical tumor (ACT) and pituitary adenoma (PA) formation. His laboratory has identified the genetic defects responsible for Carney complex, Carney Triad, the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome), and described new entities such as X-LAG (X-linked acrogigantism) and 3-PAs (the 3 Ps association of paragangliomas pheochromocytomas and PA). It was his identification of the protein kinase A (PKA) regulatory subunit type 1A (PRKAR1A) as the gene responsible for Carney complex in 2000 that led to the identification of the PRKACA gene as the most commonly mutated gene in all benign ACTs in 2014 by his and other laboratories. Dr. Stratakis described novel genes, such as GPR101 in gigantism, and succinate dehydrogenase (SDH) defects in a variety of tumors, including a disease that bears his name, and led the efforts to show that many gastric stromal sarcomas (GIST) form due to SDH deficiency. He is the author of more than 700 publications, his work has been cited >20,000 times, and he served in major Editorial roles of leading journals, including Deputy Editor, Journal of Clinical Endocrinology and Metabolism (2010-2015) and co-Editor, Hormone & Metabolic Research and Molecular & Cellular Endocrinology (2016-today). Dr. Stratakis received the 1999 Award for Excellence in Published Clinical Research and the 2009 Ernst Oppenheimer Award, both from the Endocrine Society, and the 2019 Dale Medal from the Society for Endocrinology and many other honors. He also has been named Visiting Professor in academic centers around the world and has received two honorary degrees from the Universities of Liege and Athens, respectively. As a mentor, Dr. Stratakis has trained more than 200 students, residents, pre-doctoral, post-doctoral and clinical fellows, and now nurtures the careers of junior faculty members and investigators. He has received numerous recognitions for his mentorship and teaching. Dr. Stratakis is widely recognized for his leadership, including in professional organizations. He just completed his year as the 2018-2019 Presidentof the Society for Pediatric Research (SPR) and served as NICHD Scientific Director from 2009 to 2020, where he oversaw one of the largest intramural research programs at NIH, employing more than 1,200 staff, and an annual budget of close to $200 M. Dr. Stratakis was recently selected to serve as the Executive Director of research at McGill University Hospital and CSO of the McGill Research Institute, all at Montreal, Quebec, Canada, a position he assumes as of June 1st, 2020